Targeting an epigenetic pathway to treat asthma [ 2016 - ]

Research Grant

Researchers: Dr Rhys Allan (Principal investigator) ,  A/Pr Christopher Burns

Brief description This project proposes to identify novel components and develop new inhibitors of an epigenetic pathway known to control the immune cells that cause allergic asthma. Our objective is to use these drugs to treat allergic disease.

Funding Amount $444,086.00

Funding Scheme Project Grants

Notes Standard Project Grant